Serum eotaxin levels in patients with chronic spontaneous urticaria

European Annals of Allergy and Clinical Immunology

Volumn 44, Issue 5, 2012, Pages 188-192

  Tedeschi, Alberto ^a   Asero, R ^b   Lorini, M ^a,c   Marzano, A V ^a   Cugno, M ^c  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b Clinica San Carlo   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

C reactive protein; Chronic urticaria; Eosinophils; Eotaxin

Indexed keywords

C REACTIVE PROTEIN; CETIRIZINE; DESLORATADINE; EBASTINE; EOTAXIN; FEXOFENADINE; LEVOCETIRIZINE; RUPATADINE;

ADULT; AGED; ARTICLE; AUTOLOGOUS SERUM SKIN TEST; CHRONIC URTICARIA; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE EXACERBATION; DISEASE SEVERITY; EOSINOPHIL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; REMISSION; SCORING SYSTEM; SKIN TEST;

ADULT; C-REACTIVE PROTEIN; CHEMOKINE CCL11; CHRONIC DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; URTICARIA;

EID: 84867726311     PISSN: 17641489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Grattan CE, Francis DM, Hide M, Greaves MW. Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria. Clin Exp Allergy 1991; 21(6): 695-704.
2. Hide M, Francis DM, Grattan CEH, Hakimi J, Kochan JP, Greaves MW. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993; 328(22): 1599-604.
3. Sabroe RA, GreavesMW. Chronic idiopathic urticaria with functional autoantibodies: 12 years on. Br J Dermatol. 2006; 154(5):813-9.
4. Kaplan AP, Greaves M. Pathogenesis of chronic urticaria. Clin Exp Allergy 2009; 39(6): 777-87.
5. Kessel A, Bishara R, Amital A, Bamberger E, Sabo E, Grushko G, Toubi E. Increased plasma levels of matrix metalloproteinase-9 are associated with the severity of chronic urticaria. Clin Exp Allergy. 2005; 35(2): 221-5
6. Tedeschi A, Asero R, LoriniM, Marzano AV, CugnoM. Plasma levels of matrix metalloproteinase-9 in chronic urticaria patients correlate with disease severity and C-reactive protein but not with circulating histamine-releasing factors. Clin Exp Allergy. 2010; 40(6): 875-81.
7. Kasperska-Zajac A, Sztylc J, Machura E, Jop G. Plasma IL-6 concentration correlates with clinical disease activity and serum C-reactive protein concentration in chronic urticaria patients. Clin Exp Allergy. 2011;41(10):1386-91.
8. Sabroe RA, Poon E, Orchard GE, Lane D, Francis DM, Barr RM, BlackMM, Kobza Black A, GreavesMW. Cutaneous inflammatory cell infiltrate in chronic idiopathic urticaria: comparison of patients with and without anti-FcεRIα or anti-IgE autoantibodies. J Allergy Clin Immunol 1999; 103(3Pt1): 484-93.
9. Elias J, Bosse E, Kaplan AP. Studies of the cellular infiltrate of chronic idiopathic urticaria: prominence of T-lymphocytes, monocytes, and mast cells. J Allergy Clin Immunol 1986; 78(5Pt1): 914-8.
10. Ying S, Kikuchi Y, Meng Q, Kay AB, Kaplan AP. TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction. J Allergy Clin Immunol 2002; 109(4): 694-700.
11. Peters M, Schroeter A, Kephard G, Gleich G. Localization of eosinophil granule major basic protein in chronic urticaria. J Invest Dermatol 1983; 81(1): 39-43.
12. Grattan CE, Winkelmann RK, Leiferman KM. Eosinophil major basic protein in autologous serum and saline skin tests in chronic idiopathic urticaria. Br J Dermatol 1997; 136(1): 132-148.
13. Asero R, Cugno M, Tedeschi A. Eosinophils in chronic urticaria: supporting or leading actors?WAO Journal 2009; 2: 213-7.
14. Rothenberg ME, Hogan SP. The eosinophil. Annu Rev Immunol. 2006;24:147-74
15. Kitaura M, Nakajima T, Imai T, Harada S, Combadiere C, Tiffany HL, Murphy PM, Yoshie O. Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3. J Biol Chem. 1996;271(13):7725-30.
16. Menzies-Gow A, Ying S, Sabroe I, Stubbs VL, Soler D, Williams TJ, Kay AB. Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early-and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers. J Immunol. 2002;169(5):2712-8.
17. Hossny E, Aboul-MagdM, Bakr S. Increased plasma eotaxin in atopic dermatitis and acute urticaria in infants and children. Allergy 2001; 56(10): 996-1002.
18. Caproni M, Cardinali C, Giomi B, Antiga E, D'Agata A, Walter S, Fabbri P. Serological detection of eotaxin, IL-4, IL-13, IFN-gamma, MIP-1alpha, TARC and IP-10 in chronic autoimmune urticaria and chronic idiopathic urticaria. J Dermatol Sci. 2004;36(1): 57-9
19. Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Giménez-Arnau A, Grattan CE, Kapp A, Merk HF, Rogala B, Saini S, Sánchez-Borges M, Schmid-Grendelmeier P, Schünemann H, Staubach P, Vena GA, Wedi B, Maurer M. EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy. 2009;64(10):1417-26.
20. Sabroe RA, Grattan CE, Francis DM, Barr RM, Kobza-Black A, Greaves MW. The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 1999; 140(3): 446-52.
21. Kaplan A. Inflammation in chronic urticaria is not limited to the consequences of mast cell (or basophil) degranulation. Clin Exp Allergy. 2010;40(6):834-5.
22. Moosbauer C, Morgenstern E, Cuvelier SL, Manukyan D, Bidzhekov K, Albrecht S, Lohse P, Patel KD, Engelmann B. Eosinophils are a major intravascular location for tissue factor storage and exposure. Blood 2007;109(3):995-1002.
23. Cugno M, Marzano AV, Tedeschi A, Fanoni D, Venegoni L, Asero R. Expression of tissue factor by eosinophils in patients with chronic urticaria. Int Arch Allergy Immunol. 2009;148(2):170-4.
24. Cugno M, Marzano AV, Asero R, Tedeschi A. Activation of blood coagulation in chronic urticaria: pathophysiological and clinical implications. Intern EmergMed. 2010;5(2):97-101.
25. Honda K, Chihara J. Eosinophil activation by eotaxin primes the production of reactive oxygen species from eosinophils. Allergy 1999;54(12):1262-69.
26. El-Shazly A, Ishikawa T. Novel cooperation between eotaxin and substance P in inducing eosinophil derived neurotoxin release. Mediators Inflamm 1999;8(3):177-9.